Table 1.
Basic characteristics of 951 patients with CAD without diabetes in whom FPG, 1hPG and 2hPG was available
| Variable | Patient number 951 |
|---|---|
| Age (years) | |
| Mean (SD) | 63.4 (10.1) |
| <50 | 11 (102) |
| 50–59 | 25 (238) |
| 60–69 | 35 (334) |
| >70 | 29 (277) |
| Sex | |
| Women | 25 (241) |
| Men | 75 (710) |
| Low educational level | 10 (94; n=944) |
| Current smoking | 14 (131) |
| BMI, kg/m2 | |
| <25 | 19 (179) |
| ≥25 and <30 | 46 (437) |
| ≥30 | 35 (334) |
| Central obesity | 59 (546; n=930) |
| Blood pressure (SBP/DBP≥140/90 mm Hg) | 33 (311) |
| Plasma glucose (mmol/L) | |
| ≥7 | 15 (142) |
| Fasting (mean±SD) | 6.2±0.87 |
| 1 hour postload | 10.3±2.92 |
| 2 hours postload | 8.0±2.77 |
| HbA1c (%) | |
| ≥6.5 (≥48 mmol/mol) | 7 (61; n=918) |
| Mean (%±SD) | 5.8±0.44 |
| Pharmacological treatment | |
| ASA/antiplatelets | 94 (892) |
| β-blockers | 82 (778) |
| ACE-inhibitors | 60 (564) |
| AT-II receptor antagonists | 14 (136) |
| Diuretics | 24 (230) |
| Statins | 87 (818) |
| Low physical activity (IPAQ) | 64 (591; n=918) |
Values are per cent (n) if not otherwise stated. N within brackets=number of observations in case of incomplete information.
1hPG, 1-hour plasma glucose; 2hPG, 2-hour plasma glucose; ASA, acetylsalicylic acid or Aspirin; AT, Angiotensin II; BMI, body mass index; CAD, coronary artery disease; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HbA1c, glycated haemoglobin; IPAQ, International Physical Activity Scale; SBP, systolic blood pressure.